160 related articles for article (PubMed ID: 12619488)
21. KEEPS: The Kronos Early Estrogen Prevention Study.
Harman SM; Brinton EA; Cedars M; Lobo R; Manson JE; Merriam GR; Miller VM; Naftolin F; Santoro N
Climacteric; 2005 Mar; 8(1):3-12. PubMed ID: 15804727
[TBL] [Abstract][Full Text] [Related]
22. [Prevention of the menopause: the end and the beginning].
Berrino F
Epidemiol Prev; 2002; 26(6):269-72. PubMed ID: 12619487
[No Abstract] [Full Text] [Related]
23. [Breast cancer and the use of the hormones around the menopause].
van der Mooren MJ; Kenemans P
Ned Tijdschr Geneeskd; 2004 May; 148(20):1009-10; author reply 1010-1. PubMed ID: 15181729
[No Abstract] [Full Text] [Related]
24. HRT and cardiovascular disease.
Stevenson JC
Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):109-20. PubMed ID: 19095500
[TBL] [Abstract][Full Text] [Related]
25. Treatment of menopausal vasomotor symptoms.
Obstet Gynecol; 2005 May; 105(5 Pt 1):1137-9. PubMed ID: 15863558
[No Abstract] [Full Text] [Related]
26. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
[TBL] [Abstract][Full Text] [Related]
27. [Should hormone replacement therapy for menopause be continued in diabetic women?].
Skurnik G; Touraine P
Journ Annu Diabetol Hotel Dieu; 2004; ():151-60. PubMed ID: 15259313
[No Abstract] [Full Text] [Related]
28. Commentary: hormones and heart disease: do trials and observational studies address different questions?
Stampfer M
Int J Epidemiol; 2004 Jun; 33(3):454-5. PubMed ID: 15166192
[No Abstract] [Full Text] [Related]
29. [After the early termination of the Women's Health Initiative study. New American recommendations for postmenopausal hormone therapy].
Stjernquist M;
Lakartidningen; 2003 May; 100(20):1790-7. PubMed ID: 12806859
[TBL] [Abstract][Full Text] [Related]
30. Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen.
Dubey RK; Imthurn B; Barton M; Jackson EK
Cardiovasc Res; 2005 May; 66(2):295-306. PubMed ID: 15820198
[TBL] [Abstract][Full Text] [Related]
31. [The story of the reversal of opinion about hormone replacement therapy and cardiovascular disease].
Løkkegaard EC
Ugeskr Laeger; 2005 Mar; 167(10):1166-70. PubMed ID: 15810574
[No Abstract] [Full Text] [Related]
32. [Breast cancer and the use of the hormones around the menopause].
Vandenbroucke JP; van Leeuwen FE; Helmerhorst FM
Ned Tijdschr Geneeskd; 2003 Sep; 147(38):1829-34. PubMed ID: 14533492
[TBL] [Abstract][Full Text] [Related]
33. Postmenopausal hormone therapy and breast cancer.
Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723
[TBL] [Abstract][Full Text] [Related]
34. [The Danish Nurse Cohort Study 1993-2003].
Hundrup YA; Obel EB; Rasmussen NK; Grønbaek M
Ugeskr Laeger; 2004 Apr; 166(15-16):1451-4. PubMed ID: 15146817
[No Abstract] [Full Text] [Related]
35. [Hormone replacement therapy in the climacteric--from hallelujah to requiem].
Odlind V
Lakartidningen; 2004 Jun; 101(26-27):2264-9. PubMed ID: 15281626
[No Abstract] [Full Text] [Related]
36. Observational studies and clinical trials of menopausal hormone therapy: can they both be right?
Allison MA; Manson JE
Menopause; 2006; 13(1):1-3. PubMed ID: 16607089
[No Abstract] [Full Text] [Related]
37. The missing R.
Gambacciani M; Genazzani AR
Gynecol Endocrinol; 2003 Apr; 17(2):91-4. PubMed ID: 12741416
[No Abstract] [Full Text] [Related]
38. Re: "invited commentary: Hormone therapy and risk of coronary heart disease-why renew the focus on the early years of menopause?".
Rosenberg L
Am J Epidemiol; 2007 Dec; 166(12):1480-1; author reply 1481-2. PubMed ID: 17993654
[No Abstract] [Full Text] [Related]
39. Re: "invited commentary: Hormone therapy and risk of coronary heart disease--why renew the focus on the early years of menopause?".
Dören M; Greiser EM
Am J Epidemiol; 2007 Dec; 166(12):1479-80; author reply 1481-2. PubMed ID: 17977898
[No Abstract] [Full Text] [Related]
40. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
Brinton RD
Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
